Home / Success Plan (Invoice-based) – Terms & Conditions /
Success Plan (Invoice-based) – Terms & Conditions
By subscribing to the Success Plan (Invoice-based), you agree to the following plan-specific terms. These apply in addition to the MAI CDMO Legal Terms.
With the Success Plan – Invoice-based you get:
Note: This service is provided on a non-exclusive basis. Introductions do not guarantee client responses, lead volume, or awarded projects.
Each time you receive a client payment, MAI CDMO issues an invoice for the applicable commission. Payment is due within 30 days of the invoice date, by bank transfer to the account provided on the invoice.
A “Client” means any company contacted through the MAI CDMO platform or promotional activities for a defined project and regulatory requirements analyzed by MAI CDMO.
Exception: If you can prove a pre-existing commercial relationship with the same client (by providing a formal proposal sent within the last 5 years for the same activity and regulatory requirements), the client will not be considered an introduced Client for fee purposes. If no such proof is provided, the Client will be deemed introduced by MAI CDMO, and fees will apply.
The initial term of the subscription shall be one (1) year. The subscription will automatically renew for additional one (1) year terms unless either party provides written notice or, through the platform (Account settings), its intention not to renew at least three (3) months prior to the expiration date.
2025-09-22
Connecting Leaders in Biologics Manufacturing
See more
2025-06-20
MAI CDMO is now available in 5 languages for a seamless multilingual experience.
See more
Competence Center animal health products and sterile technologies.
Activity: FDF / DRUG PRODUCTS, BIOLOGICS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: FDA (USA), EMA (EU), ANVISA (Brazil), Russian...
Our 400+ team members in Charles City specialize in late-phase and commercial API development and cGMP manufacturing.
Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Development services, Manufacturing services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
The Hérouville-Saint-Clair site, located near Caen, in Normandy, specializes in the manufacture and filling of injectable and non-injectable sterile liquid products. It has a pharmaceutical surface area of 17,900 m2 over 10 hectares and employs 290 people.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Manufacturing services,...
Batch Size / Reactor: Small, Medium
Certifications: EMA (EU GMP), FDA (cGMP), NMPA (China GMP), ANVISA...
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK), TGA...
Sterile manufacturing solutions (small molecules) in flexible bags and vials.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
Lannetts main manufacturing site sits in Seymour, Indiana, and includes capabilities for Oral Solid Dose (OSD) and Liquids.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Markets: COFEPRIS (Mexico), FDA (USA), EMA (EU), PMDA...
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
Commercial API Small Molecules Synthesis
Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, FDA (cGMP), ECOVADIS
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
CDMO Sterile Oncology Drugs
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Manufacturing services, Analytical / QC services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP)
Markets: EMA (EU)
If you have any questions or suggestions, click here. We will be happy to assist you.
